From January 2027, the Solvency II reforms will reduce capital charges for EU insurers investing in AAA CLO tranches.
Much of the discussion has understandably focused on the regulatory change itself, but I think the more interesting question is what follows.
If insurers become a more meaningful investor base for European CLOs, success is unlikely to depend solely on portfolio performance. Managers will also need the reporting capabilities, operational infrastructure and governance expected by insurance investors.
I recently explored this topic in a white paper looking at:
• The implications of the Solvency II reforms for the European CLO market
• Why operational readiness may become a competitive differentiator
• What CLO managers should be considering before the reforms take effect in January 2027
I would be interested to hear how others in the community see insurance participation evolving over the next few years. Do you expect this to materially broaden the European CLO investor base, or do operational and regulatory hurdles remain too significant?
I have attached the paper for anyone interested.
------------------------------
Vinit Sheth
Senior Consultant
Alpha Alternatives
------------------------------